206 related articles for article (PubMed ID: 9068021)
1. In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions.
Topley N
Perit Dial Int; 1997; 17(1):42-7. PubMed ID: 9068021
[TBL] [Abstract][Full Text] [Related]
2. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
3. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
4. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
5. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
6. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
[TBL] [Abstract][Full Text] [Related]
7. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.
Cooker LA; Luneburg P; Holmes CJ; Jones S; Topley N;
Perit Dial Int; 2001; 21 Suppl 3():S102-7. PubMed ID: 11887802
[TBL] [Abstract][Full Text] [Related]
9. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
Jörres A; Bender TO; Finn A; Witowski J; Fröhlich S; Gahl GM; Frei U; Keck H; Passlick-Deetjen J
Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.
Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
[TBL] [Abstract][Full Text] [Related]
13. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.
Hekking LHP; Zareie M; Driesprong BAJ; Faict D; Welten AGA; de Greeuw I; Schadee-Eestermans IL; Havenith CEG; van den Born J; Ter Wee PM; Beelen RHJ
J Am Soc Nephrol; 2001 Dec; 12(12):2775-2786. PubMed ID: 11729248
[TBL] [Abstract][Full Text] [Related]
14. Lactate-buffered and bicarbonate-buffered solutions with less glucose degradation products in a two-chamber system.
Passlick-Deetjen J; Lage C
Perit Dial Int; 2000; 20 Suppl 2():S42-7. PubMed ID: 10911642
[No Abstract] [Full Text] [Related]
15. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions.
ter Wee PM; Beelen RH; van den Born J
Kidney Int Suppl; 2003 Dec; (88):S75-83. PubMed ID: 14870880
[TBL] [Abstract][Full Text] [Related]
16. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
[TBL] [Abstract][Full Text] [Related]
17. Studying the effects of new peritoneal dialysis solutions on the peritoneum.
Chan TM; Yung S
Perit Dial Int; 2007 Jun; 27 Suppl 2():S87-93. PubMed ID: 17556337
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.
Topley N; Kaur D; Petersen MM; Jörres A; Passlick-Deetjen J; Coles GA; Williams JD
Kidney Int; 1996 May; 49(5):1447-56. PubMed ID: 8731113
[TBL] [Abstract][Full Text] [Related]
19. [Biocompatibility of dialysis fluid in peritoneal dialysis--limitations and possibilities of improvement].
Olszowska A; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):364-7. PubMed ID: 18634375
[TBL] [Abstract][Full Text] [Related]
20. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]